Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Guslandi et al. (2000) published the effects of Saccharomyces boulardii on Crohn’s disease (CD) from a small randomized phase II clinical trial.
The conclusion from the authors was: Saccharomyces boulardii may represent a useful tool in the maintenance treatment of Crohn's disease. However, in view of the product's cost, further controlled studies are needed to confirm these preliminary data.
Guslandi et al. 2000 Dig Dis Sci. 45(7):1462–1464.
…